PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.34%
Revenue growth under 50% of ADI's 16.18%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
7.29%
Gross profit growth under 50% of ADI's 20.89%. Michael Burry would be concerned about a severe competitive disadvantage.
14.75%
EBIT growth below 50% of ADI's 62.61%. Michael Burry would suspect deeper competitive or cost structure issues.
14.68%
Operating income growth under 50% of ADI's 62.61%. Michael Burry would be concerned about deeper cost or sales issues.
21.75%
Net income growth under 50% of ADI's 61.33%. Michael Burry would suspect the firm is falling well behind a key competitor.
23.26%
EPS growth under 50% of ADI's 63.64%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.81%
Diluted EPS growth under 50% of ADI's 59.09%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-1.04%
Share reduction while ADI is at 1.45%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.63%
Reduced diluted shares while ADI is at 4.02%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
9.10%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
20.02%
Similar OCF growth to ADI's 21.80%. Walter Schloss would assume comparable operations or industry factors.
-7.07%
Negative FCF growth while ADI is at 14.16%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
54.53%
Similar 10Y revenue/share CAGR to ADI's 56.70%. Walter Schloss might see both firms benefiting from the same long-term demand.
32.29%
5Y revenue/share CAGR above 1.5x ADI's 14.88%. David Dodd would look for consistent product or market expansions fueling outperformance.
2.56%
3Y revenue/share CAGR above 1.5x ADI's 1.64%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
42.74%
10Y OCF/share CAGR above 1.5x ADI's 17.73%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
6.47%
Below 50% of ADI's 13.47%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
40.02%
3Y OCF/share CAGR above 1.5x ADI's 11.79%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
99.29%
Net income/share CAGR 1.25-1.5x ADI's 70.50%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
85.55%
5Y net income/share CAGR above 1.5x ADI's 1.44%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
15.90%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
45.75%
10Y equity/share CAGR at 50-75% of ADI's 84.96%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
3.31%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
1.15%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
508.03%
Dividend/share CAGR of 508.03% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
370.06%
5Y dividend/share CAGR above 1.5x ADI's 228.37%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
203.64%
3Y dividend/share CAGR above 1.5x ADI's 20.10%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-11.01%
Firm’s AR is declining while ADI shows 23.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
7.71%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.81%
Asset growth well under 50% of ADI's 3.78%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.09%
BV/share growth above 1.5x ADI's 1.41%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
-3.80%
Our R&D shrinks while ADI invests at 2.37%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.35%
SG&A growth well above ADI's 4.58%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.